Cargando…
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection
The COVID-19 course and immunity differ in children and adults. We analyzed immune response dynamics in 28 families up to 12 months after mild or asymptomatic infection. Unlike adults, the initial response is plasmablast-driven in children. Four months after infection, children show an enhanced spec...
Autores principales: | Jacobsen, Eva-Maria, Fabricius, Dorit, Class, Magdalena, Topfstedt, Fernando, Lorenzetti, Raquel, Janowska, Iga, Schmidt, Franziska, Staniek, Julian, Zernickel, Maria, Stamminger, Thomas, Dietz, Andrea N., Zellmer, Angela, Hecht, Manuel, Rauch, Peter, Blum, Carmen, Ludwig, Carolin, Jahrsdörfer, Bernd, Schrezenmeier, Hubert, Heeg, Maximilian, Mayer, Benjamin, Seidel, Alina, Groß, Rüdiger, Münch, Jan, Kirchhoff, Frank, Bode, Sebastian F. N., Strauss, Gudrun, Renk, Hanna, Elling, Roland, Stich, Maximillian, Voll, Reinhard E., Tönshof, Burkhard, Franz, Axel R., Henneke, Philipp, Debatin, Klaus-Michael, Rizzi, Marta, Janda, Ales |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701757/ https://www.ncbi.nlm.nih.gov/pubmed/36437276 http://dx.doi.org/10.1038/s41467-022-35055-1 |
Ejemplares similares
-
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
por: Seidel, Alina, et al.
Publicado: (2023) -
Pulmonary Function and Persistent Clinical Symptoms in Children and Their Parents 12 Months After Mild SARS-CoV-2 Infection
por: Bode, Sebastian F. N., et al.
Publicado: (2022) -
Role of ABO Blood Group in SARS-CoV-2 Infection in Households
por: Janda, Ales, et al.
Publicado: (2022) -
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study
por: Haddad, Anneke, et al.
Publicado: (2022) -
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
por: Fabricius, Dorit, et al.
Publicado: (2021)